SCHEMBL4336794

SCHEMBL4336794

CC1CN(C(=O)OC(C)(C)C)CCN1C(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SETD7 Q8WTS6 2/20 0.52
USP2 O75604 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NR1H2 P55055 1/20 0.44
MAP4K4 O95819 1/20 0.43
HPGD P15428 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
EPHX2 P34913 1/20 0.42
SMARCA2 P51531 1/20 0.41
SMARCA4 P51532 1/20 0.41
PBRM1 Q86U86 1/20 0.41
SPR P35270 3/20 0.41
RECQL P46063 1/20 0.41
EPHX1 P07099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15055247 0.92 TSHR (0.53) SETD7USP2SMN1; SMN2NR1H2HPGD
SCHEMBL18689112 0.92 SETD7 (0.49) SETD7USP2SMN1; SMN2MAP4K4ALDH1A1
SCHEMBL18689110 0.92 SETD7 (0.49) SETD7USP2SMN1; SMN2MAP4K4ALDH1A1
SCHEMBL15055244 0.92 TSHR (0.53) SETD7USP2SMN1; SMN2NR1H2HPGD
SCHEMBL28055264 0.92 SETD7 (0.51) SETD7USP2SMN1; SMN2NR1H2HPGD
SCHEMBL17560369 0.90 SETD7 (0.50) SETD7USP2SMN1; SMN2NR1H2HPGD
SCHEMBL26666330 0.90 SETD7 (0.50) SETD7USP2SMN1; SMN2NR1H2HPGD
SCHEMBL17560370 0.90 SETD7 (0.50) SETD7USP2SMN1; SMN2NR1H2HPGD
SCHEMBL28060463 0.90 SETD7 (0.50) SETD7USP2SMN1; SMN2NR1H2HPGD
SCHEMBL15105056 0.90 SETD7 (0.50) SETD7USP2SMN1; SMN2NR1H2MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7569690-B2 Process for producing oxycarbonyl-substituted piperazine derivative TORAY FINE CHEMICALS CO., LTD. (JP) 2009-08-04 US disclosed
US-20060161003-A1 Process for producing oxycarbonyl-substituted piperazine derivative TORAY FINE CHEMICALS CO., LTD. (JP) 2006-07-20 US disclosed
EP-1548010-A1 PROCESS FOR PRODUCING OXYCARBONYL-SUBSTITUTED PIPERAZINE DERIVATIVE Toray Fine Chemicals Co., Ltd. (JP) 2005-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060161003-A1 Process for producing oxycarbonyl-substituted piperazine derivative DHPS, AQP4, OGFOD1 SETD7 720/4885USP2 1137/4885SMN1; SMN2 3473/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.